Skip to main content

The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billion in 2030, predicts Roots Analysis

 

Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030.”

 

The report features an extensive study of the current market landscape and future opportunities associated with the pharmaceutical contract manufacturing market in China. The study also features a detailed analysis, highlighting the capabilities of pharmaceutical CMOs in this region. Amongst other elements, the report features:

§  A detailed assessment of the current market landscape of pharmaceutical contract manufacturers in China engaged in the development of active pharmaceutical ingredients (APIs), intermediates and finished dosage formulations (FDFs). 

§  A detailed landscape of the pharmaceutical manufacturing facilities in China, including an analysis based on location of these facilities, highlighting key manufacturing hubs.

§  A brief discussion of various regulatory guidelines in China and various challenges, related to regulatory scrutiny, faced by pharmaceutical manufacturers in China.

§  Detailed profiles of key players that offer a diverse range of capabilities for the manufacturing of pharmaceutical products in China.

§  A review of the pharmaceutical manufacturing related initiatives of the top 10 big pharma players (shortlisted from the top companies of 2019 by revenues).

§  An analysis of the partnerships and acquisitions that have been established in this domain, in the recent past.

§  A detailed capacity analysis based on the installed reactor capacities of the manufacturing facilities in China.

§  A case study comparing the key characteristics of large molecule and small molecule drugs, along with details on the various steps involved in their respective manufacturing processes.

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

§  Key Geographical Regions

  • Eastern China
  • Southern China
  • Northern China 

 

§  Type of Product

 

§  Type of Drug Product

  • Solid
  • Liquid / Semi-Solid
  • Injectable
  • Others

 

§  Scale of Operation

  • Clinical
  • Commercial

 

To Request for sample report - https://www.rootsanalysis.com/reports/312/request-sample.html

 

§  Company Size

  • Small
  • Mid-Sized
  • Large / Very Large

 

 

Key players covered in the report

§  2Y-Chem

§  Aurisco Pharmaceutical

§  ChemPartner

§  Dorrapharma

§  Hubei Biocause Pharmaceutical

§  Infoark

§  Ningbo Menovo Pharmaceutical

§  Shandong Xinhua Pharmaceutical

§  Shanghai Acebright Pharmaceuticals

§  STA Pharmaceutical

§  Zhejiang Huahai Pharmaceutical

 

For more information please click on the following link:

https://www.rootsanalysis.com/reports/view_document/china-pharmaceutical-contract-manufacturing/312.html

 

Other Recent Offerings

1.     China Biopharmaceutical Contract Manufacturing Market, 2020 – 2030

2.     HPAPI and Cytotoxic Drugs Manufacturing Market (3rd Edition), 2020-2030

3.     Novel coronavirus (COVID-19): Preventive Vaccines, Therapeutics and Diagnostics in Development

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

ben.johnson@rootsanalysis.com

Facebook - https://www.facebook.com/RootsAnalysis

LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/

Twitter - https://twitter.com/RootsAnalysis

 

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Manufacturing Market Continuous by Roots Analysis

    Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing   Roots Analysis is pleased to announce the publication of its recent study, titled, “ Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030 .”   The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in continuous manufacturing (both innovator companies with in-house expertise and contract manufacturers). It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes: §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing §   Elaborate profiles of some o...
Post a Comment
Read more

The Alzheimer’s disease market is anticipated to grow at an annualized rate of over 13%, till 2030, claims Roots Analysis

  Roots Analysis has announced the addition of “ Alzheimer's Disease Market (2 nd Edition), 2021-2031 ” report to its list of offerings.   Limited treatment options and unmet needs are the key drivers of research activity in this domain. Several industry and non-industry players are presently engaged in developing various types of disease modifying interventions and drug / therapy candidates that offer symptomatic relief. Moreover, multiple venture capital firms and other strategic investors have been supporting the research related initiatives of various start-ups. Driven by a rich development pipeline and the efforts of various stakeholders, the market is anticipated to grow at a significant pace in the coming future.   To order this 150+ page report, which features 90+ figures, please visit https://www.rootsanalysis.com/reports/view_document/alzheimers-disease-market/247.html   Key Market Insights   More than 240 drug candidates for the t...
Post a Comment
Read more

Continuous Manufacturing Market (Small Molecules and Biologics) by Roots Analysis

  To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html   Key Inclusions §   A detailed assessment of the overall landscape of companies with capabilities for continuous manufacturing, along with information on a number of relevant parameters, such as year of establishment, company size, purpose of manufacturing (in-house and contract services), scale of operation (preclinical, clinical and commercial), location of headquarters, location of manufacturing facilities, type of drug molecule (biologic and small molecule), type of continuous manufacturing related service(s) offered (process development, API manufacturing, intermediate manufacturing, drug product manufacturing, and packaging and fill / finish),   type of dosage form (solid and liquid), and installed capacity and batch size (if available). §   Elaborate profiles of so...
Post a Comment
Read more